2-{8-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-3-[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]-2,8-diazaspiro[4.5]decan-2-yl}-N,N-dimethylacetamide
Chemical Structure Depiction of
2-{8-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-3-[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]-2,8-diazaspiro[4.5]decan-2-yl}-N,N-dimethylacetamide
2-{8-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-3-[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]-2,8-diazaspiro[4.5]decan-2-yl}-N,N-dimethylacetamide
Compound characteristics
Compound ID: | SD02-0345 |
Compound Name: | 2-{8-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-3-[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]-2,8-diazaspiro[4.5]decan-2-yl}-N,N-dimethylacetamide |
Molecular Weight: | 483.61 |
Molecular Formula: | C26 H37 N5 O4 |
Smiles: | CC(C)c1nnc(C2CC3(CCN(CC3)Cc3ccc4c(c3)OCCO4)CN2CC(N(C)C)=O)o1 |
Stereo: | RACEMIC MIXTURE |
logP: | 1.0567 |
logD: | -1.4772 |
logSw: | -2.0336 |
Hydrogen bond acceptors count: | 9 |
Polar surface area: | 69.675 |
InChI Key: | DAMPEBCREOIRGD-FQEVSTJZSA-N |